The 78th Annual Deming Conference on Applied Statistics will be held on December 5-9, 2022.
Below is the 2022 (78th) program.

2022 Program Schedule
DAY
01 - Sunday December 04, 2022
-
18:00 - 19:30
REGISTRATION
-
19:00 - 20:00
RECEPTION
DAY
02 - Monday December 05, 2022
-
07:00 - 07:50
BREAKFAST
Full Hot Breakfast (Covered by registration fee)
-
08:00 - 09:00SESSION KEYNOTE
Walter Young Memorial Session
Moderator: Alfred H. Balch -
09:00 - 12:15SESSION A
TITLE: Hybrid Frequentist / Bayesian Power and Bayesian Power in Planning Clinical Trials
SPEAKER: Andy P. Grieve
Moderator: Din Chen -
09:00 - 12:15SESSION B
Spatial Data Science Meets Bayesian Modeling and Inference
Sudipto Banerjee, UCLA
Moderator: Naitee Ting -
13:30 - 17:30SESSION C
Incorporating Uncertainty in Power Considerations of Clinical Trials with Applications on Equivalence Trials
SPEAKERS: Arne Ring and Rachid El-Galta, Sandoz
MODERATOR: Din Chen -
13:30 - 17:30SESSION D
Bayesian Methods for Sample Size Determinations
INSTRUCTORS: Sujit K. Ghosh, NCSU and Fei Wang, Boehringer Ingelheim
MODERATOR: Naitee Ting -
19:00 -
Speaker’s and Awards Meeting (Optional Added FeeEvent)
Speaker’s and Awards Dinner (Optional Added Fee Event)
DAY
03 - Tuesday December 06, 2022
-
08:00 - 09:00SESSION KEYNOTE
Monitoring the Data on Covid-19 Vaccines: The Challenges by Susan Ellenberg, University of Pennsylvania
Susan Ellenberg, University of Pennsylvania
Ivan S. F. Chan -
09:00 - 12:15SESSION E
Statistical Topics in Outcomes Research: Patient-Reported Outcomes, Meta-Analysis, and Health Economics
Joseph C. Cappelleri, Pfizer Inc, and Thomas Mathew, University of Maryland Baltimore County
Wenjin Wang -
09:00 - 12:15SESSION F
Adjust Overall Survival in Randomized Clinical Trials with Treatment Switching
Songzi Li, Hong Tian and Kaifeng Lu, BeiGene USA Inc.
Jingjing Ye -
12:15 - 17:30SESSION G
Estimand in Real-world Setting and Targeted Learning in Generating and Evaluating Real-world Evidence
Jie Chen, Overland Pharmaceuticals and Susan Gruber, Putnam Data Sciences
Weili He -
13:30 - 17:30SESSION H
Statistical Translation of Extrapolation: A Tutorial for Demonstrating Efficacy and Safety of Investigational Medicines in Pediatric Populations
James Travis, FDA; Margaret Gamalo, Pfizer Inc; and Jingjing Ye, BeiGene
Jingjing Ye
DAY
04 - Wednesday December 07, 2022
-
08:00 - 09:00SESSION KEYNOTE
Keynote 3: Innovative Real World Evidence Initiatives at FDA in response to the COVID-19 pandemic
Speaker: Aloka Chakravarty, PhD, FASA
Moderator: William Wang -
09:00 - 12:15SESSION I
N-of-1 Trials for Personalized Healthcare
Christopher Schmid, Brown University and Naihua Duan, Columbia University
Alfred H. Balch -
09:00 - 12:15SESSION J
Machine Learning for Statisticians
Andy Liaw and Junshui Ma, Merck & Co., Inc
Ivan S. F. Chan -
12:15 - 17:30SESSION K
Using SAS PROC BGLIMM and MCMC for Bayesian Analysis of Mixed Models
Walter Stroup, University of Nebraska
Alfred H. Balch -
12:15 - 17:30SESSION L
Safety and Benefit-Risk Evaluation with Practical Visual Analytical Tools
Melvin Munsaka, AbbVie Inc and Jim Buchanan, Covilance LLC
William Wang
DAY
05 - Thursday December 08, 2022
-
08:00 - 17:00SHORT COURSE 1 (Dec 8 -Dec 9)
Combining Information from Different Studies with Meta-Analysis and Network Meta-Analysis
Christopher Schmid and Thomas Trikalinos, Brown University
Moderator: Alfred H. Balch -
08:00 - 17:00SHORT COURSE 2 (Dec 8-Dec 9)
Multi-regional Clinical Development and Safety/Benefit-Risk evaluation
INSTRUCTOR: Bruce Binkowitz, Aloka Chakravarty, Arcutis Biotherapeutics Inc, Gang Li, Eisai Inc, Jim Buchanan, Covilance LLC, and Judy Li, BMS
MODERATOR: Ivan S. F. Chan and William Wang
DAY
06 - Friday December 09, 2022
-
08:00 - 14:10
SHORT COURSE 1 ( continued )
-
08:00 - 14:10
SHORT COURSE 2 ( continued )
All tutorial and short course titles, presenters and moderators from 1970 onward are on www.demingconference.org
Session is based on a recently published text that is available for a discounted price. All times in the schedule refer to US EST Time *Conference information with links to participate will be sent to registrants on Nov 2021